You can buy or sell AUTL and other stocks, options, ETFs, and crypto commission-free!
Autolus Therapeutics plc American Depositary Share, also called Autolus Therapeutics, is a biopharmaceutical company. It engages in the development of cancer treatments. Read More The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom.
London, Greater London
52 Week High
52 Week Low
Seeking AlphaMay 14
Autolus Therapeutics PLC. CEO Christian Itin on Q1 2019 Results - Earnings Call Transcript
Autolus Therapeutics PLC (NASDAQ:AUTL) Q1 2019 Earnings Conference Call May 14, 2019 8:30 AM ET Company Participants Silvia Taylor - VP, Corporate Affairs and Communication Christian Itin - Chairman & CEO Andrew Oakley - CFO & SVP Conference Call Participants Biren Amin - Jefferies Matthew Phipps - William Blair & Company Graig Suvannavejh - Goldman Sachs Group Operator Good day, ladies and gentlemen, and welcome to the Autolus Therapeutics First Quarter 2019 Financial Results Conference Call. [Op...
Yahoo FinanceMay 7
Autolus Therapeutics to Report First Quarter 2019 Financial Results and Host Conference Call on May 14
-$0.58 per share
-$0.69 per share